Page 2 - Crest Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crest partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crest Partners Today - Breaking & Trending Today

Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […] ....

Amyw Schulman , Securities Exchange Commission , Allspring Global Investments Holdings , Altitude Crest Partners Inc , Alnylam Pharmaceuticals Stock Down , Alnylam Pharmaceuticals Inc , Quent Capital , Investment Management , Wells Fargo Company , Morgan Stanley , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Company Profile , Alnylam Pharmaceuticals , Get Free Report , Director Amy , Exchange Commission , Pharmaceuticals Stock Down , Global Investments Holdings , Crest Partners , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of "Moderate Buy" from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year price target among […] ....

Institutional Investors Weigh In On Alnylam Pharmaceuticals , Jpmorgan Chase Co , Alnylam Pharmaceuticals , Royal Bank , Altitude Crest Partners Inc , Alnylam Pharmaceuticals Stock Performance , Alnylam Pharmaceuticals Inc , Wolfe Research , News Ratings For Alnylam Pharmaceuticals Daily , Allspring Global Investments Holdings , Analyst Recommendations For Alnylam Pharmaceuticals , Investment Management , Quent Capital , Get Free Report , Global Investments Holdings , Crest Partners , Get Free , Alnylam Pharmaceuticals Daily ,

Corbus Pharmaceuticals (NASDAQ:CRBP) Lowered to "Sell" at StockNews.com

StockNews.com lowered shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other brokerages have also recently issued reports on CRBP. Royal Bank of Canada assumed coverage on Corbus Pharmaceuticals in a research report on Monday, May 13th. […] ....

Securities Exchange Commission , Corbus Pharmaceuticals Company Profile , News Ratings For Corbus Pharmaceuticals Daily , Corbus Pharmaceuticals , Altitude Crest Partners Inc , Corbus Pharmaceuticals Stock Performance , Royal Bank , Pricet Rowe Associates Inc , Institutional Investors Weigh In On Corbus Pharmaceuticals , Janus Henderson Group , Jefferies Financial Group , Mirae Asset Global Investments Co , Corbus Pharmaceuticals Holdings Inc , Free Report , Get Free Report , Cormorant Asset Management , Exchange Commission , Asset Global Investments , Crest Partners , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily ,

enGene Holdings Inc. (NASDAQ:ENGN) Receives $34.40 Consensus Target Price from Analysts

Shares of enGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have issued a report on the stock […] ....

Leerink Partnrs , Altitude Crest Partners Inc , Omega Fund Management , Morgan Stanley , Janus Henderson Group , Vivo Capital , Dgene Inc , Gene Company Profile , Gene Holdings Inc , Gene Holdings , Get Free Report , Crest Partners , Henderson Group , Fund Management , Gene Stock Down , Gene Company , Get Free , Bacillus Calmette Gu , Gene Daily ,

enGene (NASDAQ:ENGN) Shares Down 5.7%

enGene (NASDAQ:ENGN) Shares Down 5.7%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Altitude Crest Partners Inc , Wells Fargo Company , Securities Exchange Commission , Morgan Stanley , Omega Fund Management , Fcpm Iii Services , Gene Holdings Inc , Janus Henderson Group , Dgene Inc , Gene Holdings , Get Free Report , Gene Price , Exchange Commission , Henderson Group , Crest Partners , Fund Management , Bacillus Calmette Gu , Gene Daily ,